Why the study?
Does direct intrauterine administration of antiarrhythmic drugs improve outcomes in fetuses with tachyarrhythmia and severe hydrops fetalis refractory to transplacental treatment?
Population
Fetuses with non-immune hydrops fetalis caused by tachyarrhythmias refractory to transplacental treatment
Design
Review
Authors
Loading...
May warrant consideration in refractory cases; hypothesis-generating and requires prospective validation before practice change.
Does direct intrauterine administration of antiarrhythmic drugs improve outcomes in fetuses with tachyarrhythmia and severe hydrops fetalis refractory to transplacental treatment?
Direct intravascular administration of antiarrhythmic drugs under sonographic guidance is recommended for fetal tachyarrhythmia with severe hydrops fetalis refractory to transplacental treatment.
Gembruch et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: